Invivyd, Inc. (IVVD) stock
IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)
Close on Nov 17, 2026Market cap $151.09MP/E –Yield –
Invivyd profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Invivyd's profit margin for the twelve months ending Jun 30, 2026 was -183.9%. For fiscal 2025 it was -98.2%, against -669.4% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -98.2% | +571.2 |
| FY2024 | Dec 31, 2024 | -669.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -310.8% | −186.4 |
| Q1 FY2026 | Mar 31, 2026 | -301.2% | −157.1 |
| Q4 FY2025 | Dec 31, 2025 | -64.3% | +69.1 |
| Q3 FY2025 | Sep 30, 2025 | -79.7% | +573.4 |
| Q2 FY2025 | Jun 30, 2025 | -124.4% | +1962.5 |
| Q1 FY2025 | Mar 31, 2025 | -144.1% | – |
| Q4 FY2024 | Dec 31, 2024 | -133.5% | – |
| Q3 FY2024 | Sep 30, 2024 | -653.1% | – |
| Q2 FY2024 | Jun 30, 2024 | -2086.9% | – |
See a number that looks wrong?